|
MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) is an agricultural biotech company focused on developing and commercializing natural biological solutions for high-value crops, including fruits and vegetables. The company uses novel compounds from the mustard plant to provide superior and safer alternatives to current synthetic chemicals used as pesticides, fungicides and nematicides. Management & advisors own 22% of the company’s 37 million shares outstanding.
Leveraging its innovative platform, MustGrow effectively extracts the natural defense mechanisms of the mustard seed for broad use in crop production and protection. The company uses components of mustard seed to provide high quality, organic pest control to growers facing challenges associated with soil-borne diseases and pests like nematodes. This company’s all-natural,
effective, safe and easy-to-use solution is ideal for farmers looking to raise healthy crops without chemical pesticides amid growing concerns worldwide over the negative effects of chemical pesticide solutions.
Investment Considerations:
- MustGrow uses novel plant compounds to develop superior and safer alternatives to current synthetic chemicals used as pesticides, fungicides and nematicides.
- The company leverages its innovative technology platform and the natural defensive mechanisms of the mustard plant for broad use in crop production and protection in order to provide consumers the healthy, safe and natural foods they demand.
- The company has EPA approval for the granule form of its flagship product, TerraMG, and is currently waiting to receive approval for the liquid form in the United States and Canada.
- MustGrow already has multiple projects in various stages of development, with a focus on all-natural and organic solutions for crops.
- The liquid form of TerraMG has the potential for multiple applications, thus significantly enhancing the company’s IP position.
- MustGrow is focused on the disruption of the global pesticide market, which totals $65 billion, while testing multiple applications of TerraMG and other products in significant markets.
- The company has 37 million shares outstanding; management and advisors own 22%.
|
